Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00360581 · ClinicalTrials.gov registry record · Phase 1
Preventing Postpartum Relapse to Smoking Using Yoga and Cognitive Behavioral Therapy: A Randomized Pilot Study
A Phase 1 study of Smoking Cessation, sponsored by University of Pittsburgh.
- Completed
- Registry status
- Phase 1
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT00360581: Completed Phase 1 study of Smoking Cessation, sponsored by University of Pittsburgh.
NCT00360581 is a Phase 1 study of Smoking Cessation that has completed, run by University of Pittsburgh. The registered enrollment target is 30 participants, below the 475-participant average among 188 other Smoking Cessation trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00360581, a Phase 1 study of Smoking Cessation, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to develop strategies to maintain smoking abstinence initiated in pregnancy and prevent relapse in the postpartum period.
Conditions Studied
Interventions
- BEHAVIORAL Yoga
- BEHAVIORAL Yoga and Cognitive Behavioral Therapy
Study Locations (1)
Pennsylvania
- University of Pittsburgh School of Nursing - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2006-04 |
| Est. Completion | 2008-01 |
| Phase | Phase 1 |
What the finished NCT00360581 record still lists
NCT00360581 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 475-participant average among 188 other Smoking Cessation trials with a reported enrollment target (94% lower).
The record links to 1 condition, with Smoking Cessation appearing as the primary indexed condition, and to 2 interventions - of which Yoga is the first listed.
NCT00360581 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00360581 about?
NCT00360581 is a clinical study titled "Preventing Postpartum Relapse to Smoking Using Yoga and Cognitive Behavioral Therapy: A Randomized Pilot Study". The purpose of this study is to develop strategies to maintain smoking abstinence initiated in pregnancy and prevent relapse in the postpartum period.
What is the current status of trial NCT00360581?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 30 participants. The study started on 2006-04. Estimated completion is 2008-01.
What conditions does trial NCT00360581 study?
This clinical trial studies the following conditions: Smoking Cessation.
What interventions are being tested in trial NCT00360581?
The interventions under investigation include: Yoga (BEHAVIORAL), Yoga and Cognitive Behavioral Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT00360581?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00360581 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking Cessation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00360581's enrollment target sits among peer trials
30 166th of 188 higher than 21 of 188 other Smoking Cessation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Smoking Cessation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Overcoming Nicotine Dependence to Enable Quitting
RECRUITING · Phase 1
-
Concurrent vs. Sequential Cessation of Dual Cigarette and E-cigarette Use
RECRUITING · Phase 1
-
Development of a MHBC Intervention for Weight Loss and Smoking Cessation for Pre-Bariatric Surgery Patients
RECRUITING · Phase 1
-
Harnessing the Power of Technology: MOMBA for Postpartum Smoking
COMPLETED · Phase 1
-
Contingency Management, Quitting Smoking, and ADHD
COMPLETED · Phase 1
-
A Phase I Study to Evaluate the Pharmacokinetics of Multiple Doses of Varenicline in Healthy Adolescent Smokers
COMPLETED · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia